Black Pepper Compound Boosted Endocannabinoid Levels and Produced Cannabis-Like Effects in Mice

Guineensine, a compound from black pepper, inhibited the cellular uptake of endocannabinoids at nanomolar concentrations and produced cannabis-like effects in mice that were blocked by a CB1 antagonist.

Nicolussi, Simon et al.·Pharmacological research·2014·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-00843Animal StudyPreliminary Evidence2014RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Researchers identified guineensine from Piper nigrum (black pepper) as a potent inhibitor of anandamide (AEA) cellular uptake, with an EC50 of 290 nanomolar. Guineensine also inhibited 2-AG uptake. Importantly, it did not directly interact with cannabinoid receptors, FAAH, MAGL, or the fatty acid binding protein FABP5, meaning it works through a distinct mechanism from known endocannabinoid modulators.

In mice, guineensine produced the classic tetrad of cannabinoid effects: catalepsy (immobility), hypothermia (reduced body temperature), reduced locomotion, and analgesia (pain reduction). The catalepsy and analgesia were blocked by the CB1 receptor antagonist rimonabant, confirming these effects were mediated through the endocannabinoid system.

Structure-activity analysis showed that the length of the carbon chain connecting the two functional groups of guineensine was important for its activity.

Key Numbers

EC50 for AEA uptake inhibition: 290 nM. Guineensine did not inhibit FAAH, MAGL, or serine hydrolases. Did not bind CB1, CB2, or FABP5. Produced catalepsy, hypothermia, reduced locomotion, and analgesia in mice.

How They Did This

High-content screening identified guineensine from black pepper. Its effects on endocannabinoid uptake were tested in cell lines. Activity-based protein profiling confirmed it did not inhibit serine hydrolases. In vivo effects were assessed in BALB/c mice using the cannabinoid tetrad (catalepsy, body temperature, locomotion, tail-flick analgesia). The CB1 antagonist rimonabant was used to confirm endocannabinoid system involvement.

Why This Research Matters

Guineensine represents a new class of endocannabinoid modulator with a mechanism distinct from FAAH or MAGL inhibition. Its identification in black pepper adds to the list of dietary compounds that interact with the endocannabinoid system and could serve as a scaffold for developing new drugs that enhance endocannabinoid tone without directly activating cannabinoid receptors.

The Bigger Picture

The discovery of dietary compounds that modulate the endocannabinoid system opens new avenues for both drug development and understanding how food compounds affect neurochemistry. Guineensine's unique mechanism of action (blocking cellular uptake without affecting degradation enzymes) may help identify previously unknown proteins involved in endocannabinoid transport.

What This Study Doesn't Tell Us

This was a preclinical study using cell lines and mice. The concentrations of guineensine achievable through dietary black pepper consumption are likely far below those needed for pharmacological effects. The molecular target through which guineensine blocks endocannabinoid uptake was not identified.

Questions This Raises

  • ?What is the molecular target that mediates endocannabinoid cellular uptake?
  • ?Could guineensine-based compounds be developed as therapeutic agents?
  • ?Does dietary black pepper consumption meaningfully affect endocannabinoid tone in humans?

Trust & Context

Key Stat:
EC50 of 290 nanomolar for anandamide uptake inhibition from a black pepper compound
Evidence Grade:
This is a preclinical study combining in vitro screening with in vivo mouse experiments. Findings are far from clinical application.
Study Age:
Published in 2014. Research on endocannabinoid uptake mechanisms and dietary modulators has continued.
Original Title:
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
Published In:
Pharmacological research, 80, 52-65 (2014)
Database ID:
RTHC-00843

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Does eating black pepper get you high?

No. The concentrations of guineensine needed for pharmacological effects are far higher than what normal black pepper consumption provides. This is a basic science finding identifying a molecular mechanism, not a dietary recommendation.

How does guineensine differ from other endocannabinoid-enhancing drugs?

Most known endocannabinoid enhancers work by blocking the enzymes (FAAH or MAGL) that break down endocannabinoids. Guineensine instead blocks the cellular uptake of endocannabinoids through an unknown mechanism, representing a fundamentally different pharmacological approach.

Read More on RethinkTHC

Cite This Study

RTHC-00843·https://rethinkthc.com/research/RTHC-00843

APA

Nicolussi, Simon; Viveros-Paredes, Juan Manuel; Gachet, María Salomé; Rau, Mark; Flores-Soto, Mario Eduardo; Blunder, Martina; Gertsch, Jürg. (2014). Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.. Pharmacological research, 80, 52-65. https://doi.org/10.1016/j.phrs.2013.12.010

MLA

Nicolussi, Simon, et al. "Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.." Pharmacological research, 2014. https://doi.org/10.1016/j.phrs.2013.12.010

RethinkTHC

RethinkTHC Research Database. "Guineensine is a novel inhibitor of endocannabinoid uptake s..." RTHC-00843. Retrieved from https://rethinkthc.com/research/nicolussi-2014-guineensine-is-a-novel

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.